Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

1.25
+0.02001.63%
Pre-market: 1.280.0292+2.34%08:49 EDT
Volume:1.95M
Turnover:2.38M
Market Cap:163.08M
PE:-2.00
High:1.27
Open:1.20
Low:1.18
Close:1.23
52wk High:1.35
52wk Low:0.5062
Shares:130.46M
Float Shares:95.79M
Volume Ratio:0.45
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6241
EPS(LYR):-0.6241
ROE:-1653.15%
ROA:-198.76%
PB:-24.44
PE(LYR):-2.00

Loading ...

Immunic Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 13, 2025

Biotech Immunic's Q3 net loss widens

Reuters
·
Nov 13, 2025

Immunic reports Q3 EPS (13c), consensus (18c)

TIPRANKS
·
Nov 13, 2025

Immunic Q3 EPS $(0.13) Beats $(0.18) Estimate

Benzinga
·
Nov 13, 2025

Immunic Inc. reports third quarter net loss of $25.6 million

Reuters
·
Nov 13, 2025

Immunic Inc. Reports Third Quarter 2025 Financial Results and Updates on Multiple Sclerosis Trials

Reuters
·
Nov 13, 2025

Immunic Q3 Income From Operations USD -25.993 Million

THOMSON REUTERS
·
Nov 13, 2025

Immunic Q3 Basic EPS USD -0.13

THOMSON REUTERS
·
Nov 13, 2025

Immunic- Top-Line Data From Twin Phase 3 Ensure-1 and Ensure-2 Trials in Rms Expected by 2026 End

THOMSON REUTERS
·
Nov 13, 2025

Immunic: Co Does Not Have Adequate Liquidity to Fund Its Operations for at Least 12 Months From Sept 30, 2025, Without Raising Additional Capital

THOMSON REUTERS
·
Nov 13, 2025

Immunic initiated with a Buy at Roth Capital

TIPRANKS
·
Nov 07, 2025

Immunic Inc. to Participate in BIO-Europe Conference

Reuters
·
Oct 29, 2025

Immunic initiated with a Buy at Ladenburg

TIPRANKS
·
Oct 17, 2025

Immunic management to meet with B. Riley

TIPRANKS
·
Oct 10, 2025

Immunic Inc. to Present Data on IMU-856 at United European Gastroenterology Week

Reuters
·
Oct 01, 2025

Immunic Initiated at Buy by Chardan Capital

Dow Jones
·
Sep 29, 2025

Chardan Initiates Immunic at Buy With $3 Price Target

MT Newswires Live
·
Sep 29, 2025

Immunic Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 25, 2025

Eqs-News: Immunic Presented Key Vidofludimus Calcium Data at the 41St Congress of Ectrims, Highlighting Its Potential in Multiple Sclerosis

THOMSON REUTERS
·
Sep 25, 2025